PATH | VRL
Menu

Find resources

Total results with these characteristics: 155

Disease: Influenza

Page 6 of 8
Progress with Human H5N1 Vaccines: A Perspective From Industry

This article, published in Expert Review of Vaccines, offers an industry perspective on the progress made toward preparedness for a potential human influenza H5N1 pandemic, with a review of research, development, testing, and current …

Author: Palache B, Krause R

Publication date: 2009

Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health …

Author: PATH

Publication date: 2012

Protecting Mother and Baby From Infectious Diseases

This fact sheet describes PATH’s work in maternal immunization—an approach of vaccinating during pregnancy to protect the mother and baby. It covers work across vaccine projects targeting respiratory syncytial virus, influenza, group B …

Author: PATH

Publication date: 2017

Public Health Response to Influenza A(H1N1) as an Opportunity to Build Public Trust

This commentary, published in the Journal of the American Medical Association, reviews the public health response to the 2009 influenza A(H1N1) pandemic and suggests how this situation provided an opportunity to build public trust in vaccines. …

Author: Larson HJ, Heymann DL

Publication date: 2010

PubMed Searches: Influenza

These pre-formatted PubMed searches will retrieve journal citations and available abstracts that address disease burden, vaccine efficacy and benefits, and model programs, among other relevant issues related to influenza. Documents may be ordered …

Author: Various

Report of the Second WHO Consultation on the Global Action Plan for Influenza Vaccines (GAP)

This report of the second World Health Organization Consultation on the Global Action Plan for Influenza Vaccines (GAP-II) held July 12 to 14, 2011, summarizes the overview of GAP activities in the first five years and proposed action points …

Author: World Health Organization

Publication date: 2012

Response to a Monovalent Influenza A (H1N1) 2009 Vaccine

This article, published in The New England Journal of Medicine, describes the methods, results, and conclusions from a randomized observer-blind, parallel-group trial evaluating two doses of an inactivated, split-virus 2009 influenza A(H1N1) vaccine …

Author: Greenberg ME, Lai MH, Hartel GF, et al.

Publication date: 2009

Response to the 2009 Pandemic: Effect on Influenza Control in Wealthy and Poor Countries

The authors of this article, published in Vaccine, address the hard choices that must be made early in a pandemic and explore the context in which these decisions were made during the 2009 influenza pandemic. They argue that the only way to assure …

Author: Monto AS, Black S, Plotkin SA, Orenstein WA

Publication date: 2011

Responses to Avian Influenza and State of Pandemic Readiness: Fourth Global Progress Report

This report focuses on progress with responses to avian influenza and with pandemic preparedness between June 2007 and June 2008. Where data allow, the report looks back over the last three years. It also: 1) describes international financial …

Author: United Nations System Influenza Coordinator, The World Bank

Publication date: 2008

Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture

This article, published in the Journal of Infectious Diseases, describes a novel cell culture-derived influenza vaccine (CCIV) produced in Madin-Darby canine kidney cells. The Phase 3, multicenter study in Poland observed that CCIV was well …

Author: Szymczakiewicz-Multanowska A, Groth N, Bugarini R, et al.

Publication date: 2009

Safety and Immunogenicity of ASO3(B) Adjuvanted Split Virion Versus Non-adjuvanted Whole Virion H1N1 Influenza Vaccine in UK Children Aged 6 Months-12 Years: Open Label, Randomised, Parallel Group, Multicentre Study

This article, published through Online First of the British Medical Journal, details a study wherein researchers evaluated the safety, tolerability, and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus …

Author: Waddington CS, Walker WT, Oeser C, et al.

Publication date: 2010

Safety of Russian-Backbone Seasonal Trivalent, Live-Attenuated Influenza Vaccine in a Phase II Randomized Placebo-Controlled Clinical Trial Among Children in Urban Bangladesh

This article, published in Vaccine, reports the results of a study to evaluate the safety of a Russian-backbone, seasonal trivalent, live-attenuated influenza vaccine (LAIV) in children aged 24 through 59 months in Bangladesh. The authors found that …

Author: Ortiz JR, Goswami D, Lewis KDC, et al.

Publication date: 2015

Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review

This article, published in Pediatrics, reviews the existing literature on the safety of routine vaccines recommended for children in the United States. The authors found evidence that some vaccines are associated with serious adverse events; …

Author: Maglione MA, Das L, Raaen L, et al.

Publication date: 2014

Scientific Barriers to Developing Vaccines Against Avian Influenza Viruses

This review, published in Nature Reviews Immunology, discusses gaps in the knowledge of how avian influenza viruses work in humans and the the status of influenza vaccine development as of 2007. It also provides a general overview of the features of …

Author: Subbarao K, Joseph T

Publication date: 2007

Seasonal Influenza Vaccine Provision in 157 Countries (2004-2009) and the Potential Influence of National Public Health Policies

This article, published in Vaccine, details the results of a survey of global influenza vaccine supply covering 157 countries from 2004 to 2009. The authors find that global annual vaccine provision increased 72 percent to 449 million doses during …

Author: Palache A

Publication date: 2011

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

This article, published in The Journal of Infectious Diseases, examines the antigenic distance hypothesis (AHD) in the context of serial influenza vaccination in Canada. The study found that the effects of repeat influenza vaccination varied …

Author: Skowronski DM, Chambers C, De Serres G, et al.

Publication date: 2017

Skin Vaccination Summit 2013

This special issue of Vaccine contains ten articles that feature innovative research around cutaneous immunization, as presented at the 2013 Skin Vaccination Summit in Seattle, Washington. The issue highlights the various technologies and strategies …

Author: Teunissen MBM, Zehrung D, eds.

Publication date: 2015

Stabilization of HAC1 Influenza Vaccine by Spray Drying: Formulation Development and Process Scale-Up

This article, published in Pharmaceutical Research, reports on a study that aimed to develop a stable formulation of a recombinant H1N1 influenza hemagglutinin vaccine candidate using spray-drying production. The study results demonstrated the …

Author: Zhu C, Shoji Y, McCray S, et al.

Publication date: 2014

Stabilizing Influenza Vaccines

If a highly virulent pandemic strain were to emerge in today’s interconnected world, influenza has the potential to kill millions of people, especially in developing countries with limited to no resources for pandemic planning, preparedness, and …

Author: PATH

Publication date: 2013

State of the World's Vaccines and Immunization, Third Edition

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

Author: World Health Organization, United Nations Children's Fund, World Bank

Publication date: 2009

Page 6 of 8